Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Operating Leases (2019 - 2025)

Sanara MedTech (SMTI) has disclosed Operating Leases for 7 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases rose 63.62% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Sep 2025, up 63.62%, and an annual FY2024 reading of $1.2 million, down 28.8% over the prior year.
  • Operating Leases was $2.3 million for Q3 2025 at Sanara MedTech, up from $1.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $2.3 million in Q3 2025 and bottomed at $222151.0 in Q4 2021.
  • Average Operating Leases over 5 years is $1.2 million, with a median of $1.2 million recorded in 2025.
  • The sharpest move saw Operating Leases surged 477.1% in 2023, then crashed 45.7% in 2025.
  • Year by year, Operating Leases stood at $222151.0 in 2021, then surged by 127.45% to $505291.0 in 2022, then surged by 243.85% to $1.7 million in 2023, then dropped by 28.8% to $1.2 million in 2024, then surged by 86.13% to $2.3 million in 2025.
  • Business Quant data shows Operating Leases for SMTI at $2.3 million in Q3 2025, $1.2 million in Q2 2025, and $1.1 million in Q1 2025.